Skip to main content

BioAdvance investments hit $3.2M during first half of fiscal 2018

Its early-stage life sciences fund added six new companies to its portfolio.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.